ECONOMIC IMPACT OF NON-RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS PATIENTS

被引:0
|
作者
Sharma, Parivrudh [1 ]
Crighton, Lynne [2 ]
Vijayan, Balasubramaniam [3 ]
English, Shirley [3 ]
Mukhopadhya, Ashis [3 ]
机构
[1] Univ Aberdeen, Aberdeen, Scotland
[2] Aberdeen Royal Infirm, Pharm Dept, Aberdeen, Scotland
[3] Aberdeen Royal Infirm, Dept Digest Disorders, Aberdeen, Scotland
关键词
D O I
10.1136/gutjnl-2019-BSGAbstracts.244
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PTU-035
引用
收藏
页码:A129 / A130
页数:2
相关论文
共 50 条
  • [41] External Validation of the United Kingdom-Primary Biliary Cholangitis Risk Scores of Patients With Primary Biliary Cholangitis Treated With Ursodeoxycholic Acid
    Cheung, Angela C.
    Gulamhusein, Aliya F.
    Juran, Brian D.
    Schlicht, Erik M.
    Mccauley, Bryan M.
    De Andrade, Mariza
    Atkinson, Elizabeth J.
    Lazaridis, Konstantinos N.
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (06) : 676 - 682
  • [42] Primary biliary cholangitis: histological and clinical liver progression in non responders to ursodeoxycholic acid
    Cacciato, V.
    Benizzelli, G.
    Grillo, F.
    Borro, P.
    Marenco, S.
    Pasta, A.
    Picciotto, A.
    Labanca, S.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E35 - E36
  • [43] What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis?
    Wong, Lin Lee
    Hegade, Vinod S.
    Jones, David E. J.
    DIGESTIVE DISEASES, 2017, 35 (04) : 359 - 366
  • [44] Ursodeoxycholic Acid is Associated with a Prolonged Transplant-free Survival in All Patients with Primary Biliary Cholangitis - there is no such thing as non-response.
    van der Meer, Adriaan J.
    Harms, Maren H.
    Corpechot, Christophe
    Thorburn, Douglas
    Lammers, Willem J.
    Invernizzi, Pietro
    Janssen, Harry L.
    Battezzati, Pier Maria
    Nevens, Frederik
    Lindor, Keith D.
    Floreani, Annarosa
    Ponsioen, Cyriel Y.
    Mayo, Marlyn J.
    Pares, Albert
    Mason, Andrew
    Kowdley, Kris V.
    Hirschfield, Gideon M.
    van Buuren, Henk R.
    Hansen, Bettina E.
    HEPATOLOGY, 2017, 66 : 155A - 155A
  • [45] Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid
    Ding, Dawei
    Guo, Guanya
    Liu, Yansheng
    Zheng, Linhua
    Jia, Gui
    Deng, Juan
    Sun, Ruiqing
    Wang, Xiufang
    Guo, Changcun
    Shang, Yulong
    Han, Ying
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (12) : 3487 - 3495
  • [46] Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators
    Qian, Jian-Dan
    Yao, Tian-Tian
    Wang, Yan
    Wang, Gui-Qiang
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (06) : 874 - 884
  • [47] ADEQUATE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: IS NORMALIZATION OF SERUM LIVER TESTS IMPORTANT?
    Corpechot, Christophe
    Lemoinne, Sara
    Hansen, Bettina E.
    Hirschfield, Gideon
    Gulamhusein, Aliya
    Montano-Loza, Aldo J.
    Lytvyak, Ellina
    Schramm, Christoph
    Pares, Albert
    Olivas, Ignasi
    Eaton, John E.
    Osman, Karim
    Dalekos, George N.
    Gatselis, Nikolaos K.
    Nevens, Frederik
    Cazzagon, Nora
    Zago, Alessandra
    Russo, Francesco Paolo
    Abbas, Nadir
    Trivedi, Palak
    Thorburn, Douglas
    Saffioti, Francesca
    Barkai, Lazlo
    Roccarina, Davide
    Calvaruso, Vincenza
    Fichera, Anna
    Medina-Morales, Esli
    Bonder, Alan
    Patwardhan, Vilas
    Villamil, Alejandra Gracia
    Sobenko, Natalia
    Rigamonti, Cristina
    Carbone, Marco
    Invernizzi, Pietro
    Cristoferi, Laura
    Van der Meer, Adriaan
    De Veer, Rozanne
    Zigmond, Ehud
    Yehezkel, Eyal
    Kremer, Andreas E.
    Deibel, Ansgar
    Bruns, Tony
    Grosse, Karsten
    Wetten, Aaron
    Dyson, Jessica
    Jones, David
    Dumortier, Jerome
    Pageaux, Georges-Philippe
    De Ledinghen, Victor
    Chazouilleres, Olivier
    HEPATOLOGY, 2022, 76 : S1480 - S1481
  • [48] An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid
    Liu, Chung H.
    Yang, Guo-Xiang
    Johnson, Cole R.
    Dhaliwal, Sandeep S.
    Levy, Cynthia
    Peters, Marion G.
    Vierling, John M.
    Gershwin, M. Eric
    Bowlus, Christopher L.
    HEPATOLOGY, 2017, 66 : 160A - 160A
  • [49] BIOCHEMICAL RESPONSE TO BEZAFIBRATE AMONGST PATIENTS WITH PBC AND URSODEOXYCHOLIC ACID NON-RESPONSE
    Marra, Fiona
    Boyle, Alison
    Morris, Jude
    Priest, Matthew
    Barclay, Stephen
    GUT, 2023, 72 : A39 - A39
  • [50] BIOCHEMICAL RESPONSE TO BEZAFIBRATE AMONGST PATIENTS WITH PBC AND URSODEOXYCHOLIC ACID NON-RESPONSE
    Marra, Fiona
    Boyle, Alison
    Morris, Jude
    Priest, Matthew
    Barclay, Stephen
    GUT, 2023, 72 (SUPPL_3) : A40 - A40